Yield10 Bioscience, Inc. financial data

Symbol
YTEN on Nasdaq
Location
19 Presidential Way, Suite 201, Woburn, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
METABOLIX, INC. (to 1/6/2017), METABOLIX INC (to 7/14/2006)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 56.6 % -84.1%
Debt-to-equity -516 % -847%
Return On Equity 1.09K %
Return On Assets -262 % -82.1%
Operating Margin -4.35K % -12.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.4M shares +204%
Common Stock, Shares, Outstanding 642K shares -87.4%
Entity Public Float 9.84M USD +11%
Common Stock, Value, Issued 6K USD -88.2%
Weighted Average Number of Shares Outstanding, Basic 519K shares +149%
Weighted Average Number of Shares Outstanding, Diluted 519K shares +149%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 300K USD -16.9%
Costs and Expenses 13.4M USD -6.54%
Operating Income (Loss) -13.1M USD +6.27%
Nonoperating Income (Expense) -88K USD -247%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.5M USD -7.79%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -13.1M USD +6.22%
Earnings Per Share, Basic 11.6 USD/shares +73.7%
Earnings Per Share, Diluted 11.6 USD/shares +73.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.6M USD -11.7%
Cash, Cash Equivalents, and Short-term Investments 1.07M USD -75.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 2.12M USD -13.1%
Property, Plant and Equipment, Net 487K USD -31.9%
Operating Lease, Right-of-Use Asset 1.53M USD -17.7%
Other Assets, Noncurrent 57K USD +3.64%
Assets 4.24M USD -20.5%
Accounts Payable, Current 1.65M USD +233%
Employee-related Liabilities, Current 431K USD +82.6%
Accrued Liabilities, Current 1.19M USD +0.25%
Liabilities, Current 6.21M USD +174%
Operating Lease, Liability, Noncurrent 1.35M USD -29.9%
Other Liabilities, Noncurrent 5K USD -58.3%
Liabilities 7.56M USD +80.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -262K USD -12.9%
Retained Earnings (Accumulated Deficit) -417M USD -3.26%
Stockholders' Equity Attributable to Parent -3.31M USD -390%
Liabilities and Equity 4.24M USD -20.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -903K USD +66.1%
Net Cash Provided by (Used in) Financing Activities 1.21M USD +759%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 642K shares -87.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 312K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.64M USD -20.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 68K USD +580%
Deferred Tax Assets, Valuation Allowance 14.5M USD +35.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 15M USD +32.1%
Operating Lease, Liability 2.19M USD -17.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.2M USD +6.27%
Lessee, Operating Lease, Liability, to be Paid 2.88M USD -20.3%
Property, Plant and Equipment, Gross 2.05M USD +1.64%
Operating Lease, Liability, Current 687K USD +16.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 833K USD +8.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 810K USD +8.14%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 264K USD -35.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 786K USD -0.88%
Deferred Tax Assets, Operating Loss Carryforwards 9.78M USD +40.6%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 25K USD -96.7%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 66K USD -4.35%
Deferred Tax Assets, Net of Valuation Allowance 480K USD -23.8%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%